Third international symposium on drug-impaired driving
The Third international symposium on drug-impaired driving took place on 23 October 2017 in Lisbon immediately prior to the Second European conference on addictive behaviours and dependencies (24-26 October). The symposium was a collaborative effort between the EMCDDA, the Canadian Centre on Substance Use and Addiction (CCSA), the National Institute on Drug Abuse International Program (NIDA) and the New Zealand Drug Foundation.
With cannabis use and policy evolving internationally, drug-impaired driving has become an increasingly relevant issue. This international symposium put the spotlight on key developments relevant to road safety in recent years and highlighted the implications of these for drug-impaired driving. The prevalence of drug-impaired driving has begun to rival that of alcohol-impaired driving in some parts of the world, resulting in a greater focus on the ability to detect drug-impaired drivers using roadside screening tools. Similarly, with the changes in cannabis policy, many jurisdictions are working towards or have already implemented laws that establish ‘per se’ limits for drug use. With these significant changes in mind, mobilisation of research and collaboration of efforts will help us to navigate this growing area of concern. The objective of the symposium was to bring together key stakeholders who have advanced the field — whether it be through detection technology, innovation in prevention or experience in developing new drug policy — to share their experiences and lessons learned and to develop next steps to effectively address drug-impaired driving. This symposium gave participants the opportunity to learn about the latest developments in the field, highlight new research and identify gaps still needing attention.
The symposium is a collaborative effort between the Canadian Centre on Substance Use and Addiction (CCSA), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the National Institute on Drug Abuse International Program (NIDA) and the New Zealand Drug Foundation.
The Lisbon Congress Centre is located close to the river Tagus and the historical and cultural district of Belém, just a few minutes from the city centre, well
served by public transport. The ‘3rd international symposium on drug-impaired driving’ is taking place on 23 October in Lisbon
immediately prior to Lisbon Addictions 2017, the Second European conference on addictive behaviours and dependencies (24–26 October 2017).
Publications and resources
- EMCDDA Insights: Drug use, impaired driving and traffic accidents, second edition (2014)
- EMCDDA Thematic paper: Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project
- Drug-Impaired Driving Toolkit
- Oral Fluid Drug Screening Policy Brief
- Drug Evaluation and Classification Program Policy Brief
- Clearing the Smoke on Cannabis: Cannabis Use and Driving
Other relevant links and documents
- First international symposium on Drug Impaired Driving
- Towards a comprehensive framework addressing drugs and driving
- Second international symposium on Drug Impaired Driving
- Second European conference on addictive behaviours and dependencies
- World Health Organization: Drug use and road safety
- International Council on Drugs, Alcohol and Traffic Safety